SJ

Sikharani Jena

Active Director Director DIN 08100189
DIN 08100189 First appointment Apr 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Sikharani Jena

Data last updated:

Sikharani Jena is a Director at Shawna Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Shawna Pharmaceutical Private Limited reported revenue of ₹80.9 Lakh (FY 2025).

DIN 08100189
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2018
Oldest Company Age 8 yrs
Largest company Shawna Pharmaceutical Private Limited · ₹80.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Apr 20182018₹80.9 Lakh (FY 2025)Active

Board colleagues of Sikharani Jena

NameDINCompanyDesignation
Manini Rani Jena08100188Shawna Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shawna Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sikharani Jena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sikharani Jena

Sikharani Jena currently holds 1 directorship: Shawna Pharmaceutical Private Limited (Director, since 02 Apr 2018, revenue ₹80.9 Lakh (FY 2025)).

Sikharani Jena was first appointed on 02 Apr 2018 as Director at Shawna Pharmaceutical Private Limited.

The current boards of Sikharani Jena's companies include Manini Rani Jena (Shawna Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available